Alphabet’s Verily plans cost cuts amid pressure on Other Bets unit – WSJ

Alphabet's health science unit is planning additional expense cuts after losing more money than expected so far this year, the Wall Street Journal reported on Wednesday, citing an internal presentation. Verily Life Sciences posted wider-than-expected operating losses through June, missing its projections by $17 million, the report said. Part of Google parent Alphabet's Other Bets unit, which was born out of the Google X research program in 2015, Verily already laid off employees and discontinued some products earlier this year, the report added.